OBJECTIVE: To compare in details the effects of urologically used alpha(1)-blockers alfuzosin and tamsulosin on the cardiovascular responses to passive orthostasis. METHODS: The responses to passive orthostasis (tilt provocation at 60 degrees for 8 min) were measured in normotensive healthy volunteers withfinger blood pressure method and whole-body impedance cardiography prior to the administration of the drugs as well as three days after the beginning of the randomised, double-blind medications. The parallel treatments were standard clinically used doses of alpha(1)-blockers alfuzosin (5 mg twice daily, n=10), tamsulosin (0.4 mg once daily, n=10), or placebo (n=11). RESULTS: When measured prior to the head-up tilt test in supine position, neither alfuzosin nor tamsulosin significantly changed any of the cardiovascular variables. During the passive orthostasis, however, both tamsulosin and alfuzosin reduced systemic vascular resistance index compared to pre-drug responses (-540 and -462 dyns/cm(5)m(2), respectively, p<0.05). Both drugs also augmented orthostatic responses of heart rate (11 and 9 bpm, respectively, p<0.05) and cardiac index (0.50 and 0.40 l/min/m(2), respectively, p<0.05) but not those of stroke index when compared to the responses during placebo or before the administration of the drugs. The alfuzosin and tamsulosin groups did not significantly differ from each other in terms of any parameter. CONCLUSIONS: Both alfuzosin and tamsulosin have clear cardiovascular effects, which are most strikingly evident in the influences on systemic vascular resistance and cardiac output.
RCT Entities:
OBJECTIVE: To compare in details the effects of urologically used alpha(1)-blockers alfuzosin and tamsulosin on the cardiovascular responses to passive orthostasis. METHODS: The responses to passive orthostasis (tilt provocation at 60 degrees for 8 min) were measured in normotensive healthy volunteers with finger blood pressure method and whole-body impedance cardiography prior to the administration of the drugs as well as three days after the beginning of the randomised, double-blind medications. The parallel treatments were standard clinically used doses of alpha(1)-blockers alfuzosin (5 mg twice daily, n=10), tamsulosin (0.4 mg once daily, n=10), or placebo (n=11). RESULTS: When measured prior to the head-up tilt test in supine position, neither alfuzosin nor tamsulosin significantly changed any of the cardiovascular variables. During the passive orthostasis, however, both tamsulosin and alfuzosin reduced systemic vascular resistance index compared to pre-drug responses (-540 and -462 dyns/cm(5)m(2), respectively, p<0.05). Both drugs also augmented orthostatic responses of heart rate (11 and 9 bpm, respectively, p<0.05) and cardiac index (0.50 and 0.40 l/min/m(2), respectively, p<0.05) but not those of stroke index when compared to the responses during placebo or before the administration of the drugs. The alfuzosin and tamsulosin groups did not significantly differ from each other in terms of any parameter. CONCLUSIONS: Both alfuzosin and tamsulosin have clear cardiovascular effects, which are most strikingly evident in the influences on systemic vascular resistance and cardiac output.
Authors: Joachim Troost; Shinji Tatami; Yasuhiro Tsuda; Michaela Mattheus; Ludwig Mehlburger; Martina Wein; Martin C Michel Journal: Br J Clin Pharmacol Date: 2011-08 Impact factor: 4.335